Options for hip replacement: Evidence from CADTH’s Rapid Response Service

Canada’s health technology assessment (HTA) organizations provide Canadians with independent, evidence-based information on drugs and other health technologies. HTA allows decision-makers to balance the...

Self-monitoring of blood glucose in Type 2 Diabetes

Type 2 diabetes is a growing epidemic with significant implications for Canadians and the Canadian health care system. One aspect of diabetes management that...

Anti-inflammatory drugs: What’s the evidence?

Traditional non-steroidal anti-inflammatory drugs (NSAIDs) include ibuprofen (Advil, Motrin), diclofenac (Voltaren), naproxen (Naprosyn), and others. These drugs are widely available in many dosage forms...

New treatment options for Multiple Sclerosis

Multiple Sclerosis (MS) is a chronic and often disabling disease that attacks the central nervous system and causes symptoms like numbness, difficulty walking, blurred...

A decade of the Common Drug Review

Within the health care arena, how many examples of federal, provincial and territorial collaboration can you name?  How many have endured for over a...

Preventing strokes in patients with atrial fibrillation: What’s the evidence?

Atrial fibrillation (AFib or AF) is the most common abnormal heart rhythm, affecting an estimated one to two per cent of our population —...

Treating Schizophrenia: What’s the evidence?

Schizophrenia is a chronic mental illness that requires lifelong treatment. Symptoms can be highly disruptive to a patient’s life and include hallucinations, delusions, cognitive...

Latest News

X
X